These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 4822023)
1. Program for bacterial surveillance of intravenous admixtures. Ravin R; Bahr J; Luscomb F; Gooch J; Mutter S; Spittell SD Am J Hosp Pharm; 1974 Apr; 31(4):340-7. PubMed ID: 4822023 [No Abstract] [Full Text] [Related]
2. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations]. Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of two sterility testing methods for intravenous admixtures. Condella F; Eichelberger K; Foote LC; Griffin RE Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270 [TBL] [Abstract][Full Text] [Related]
4. Control of the aseptic processing environment. Frieben WR Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522 [TBL] [Abstract][Full Text] [Related]
5. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973 [TBL] [Abstract][Full Text] [Related]
6. Draft technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. American Society of Hospital Pharmacists, Council on Professional Affairs. Am J Hosp Pharm; 1993 Jul; 50(7):1440-52. PubMed ID: 8362882 [No Abstract] [Full Text] [Related]
7. Evaluation of laminar air flow and nursing station environments for the preparation of intravenous admixtures. Morgan E; Fincher JH; Sadik F; Mikeal RL Am J Hosp Pharm; 1972 Dec; 29(12):1020-4. PubMed ID: 4646699 [No Abstract] [Full Text] [Related]
8. Microbial contamination of glass bottle (open-vented) and plastic bag (closed-nonvented) intravenous fluid delivery systems. Poretz DM; Guynn JB; Duma RJ; Dalton HP Am J Hosp Pharm; 1974 Aug; 31(8):726-32. PubMed ID: 4604770 [No Abstract] [Full Text] [Related]
9. Contamination of sterile fluids. Ayliffe G; Lowbury EJ; Phillips I; Williams JD Br Med J; 1978 Jul; 2(6130):123. PubMed ID: 667554 [No Abstract] [Full Text] [Related]
10. Development of i.v. push guidelines. Sullivan V; Koch KE Am J Hosp Pharm; 1992 Oct; 49(10):2427, 2433. PubMed ID: 1442814 [No Abstract] [Full Text] [Related]
11. Reporting drug product defects--JCAHO. Hoffmann RP Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199 [No Abstract] [Full Text] [Related]
19. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures. Zellmer WA Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972 [No Abstract] [Full Text] [Related]
20. [Program of bacteriological control in the Hospital de Pediatria del Centro Médico Nacional del Instituto Mexicano del Serguro Social]. Avila-Cisneros I; Resano-Pérez F; Luna-Castro M; Zúñiga-Tellería V Bol Med Hosp Infant Mex; 1975; 32(1):169-88. PubMed ID: 1109287 [No Abstract] [Full Text] [Related] [Next] [New Search]